ibuprofen + aprepitant

Ibuprofen + aprepitant is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Ibuprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID) that acts as an analgesic, antipyretic, and anti-inflammatory agent by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins involved in pain, inflammation, and fever[4]. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptor; it is primarily used to prevent acute and delayed nausea and vomiting associated with chemotherapy or surgery by blocking the action of substance P in the central nervous system[2][5]. This combination may be considered for patients requiring both pain management (ibuprofen) and prevention or treatment of nausea/vomiting (aprepitant), though no fixed-dose commercial product exists. Caution should be exercised due to potential pharmacokinetic interactions—aprepitant may reduce blood levels and effects of ibuprofen[1][3].